Background: The QOL-PCD questionnaire is a recently developed Health Related Quality of Life (HRQoL) instrument for Primary Ciliary Dyskinesia. The aim of this study was to translate the adult QOL-PCD questionnaire into Greek language and to conduct psychometric validation to assess its performance.

Methods: Forward translations to Greek and backward translation to English were performed, followed by cognitive interviews in 12 adult PCD patients. The finalized translated version was administered to a consecutive sample of 31 adult, Greek speaking PCD patients in Cyprus for psychometric validation, which included assessment of internal consistency, test-retest reliability, construct and convergent validity. Internal consistency was assessed by Cronbach's alpha test in terms of the overall and sub-scales. Test-retest reliability was assessed by repeat administration of the questionnaire within 2 weeks and calculation of the intra-class correlation (ICC). Construct validity was assessed by comparing different groups of patients based on a-priori hypotheses and convergent validity was evaluated by examining associations between the QOL-PCD and SF-36 questionnaires.

Results: Moderate to good internal consistency was observed (Cronbach's α: 0.46-0.88 across sub-scales) and test-retest reliability assessment demonstrated good repeatability for most scales (ICC: 0.67-0.91 across subscales). Patients of female gender, older age and lower lung function exhibited lower QOL-PCD scores in general, while high correlations for most QOL-PCD scales with corresponding SF-36 scales were observed, in particular for physical functioning (r = 0.78, p < 0.05).

Conclusion: The adult version of QoL-PCD questionnaire has been translated according to international guidelines resulting to a cross-culturally validated Greek version which exhibited moderate to good metric properties in terms of internal consistency, stability, known-group and convergent validity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178983PMC
http://dx.doi.org/10.1186/s12955-020-01360-wDOI Listing

Publication Analysis

Top Keywords

qol-pcd questionnaire
12
internal consistency
12
test-retest reliability
12
health quality
8
quality life
8
primary ciliary
8
ciliary dyskinesia
8
patients cyprus
8
psychometric validation
8
pcd patients
8

Similar Publications

Article Synopsis
  • - Primary ciliary dyskinesia (PCD) is a rare genetic disorder affecting cilia function, impacting respiratory health, with no cure available; supportive therapies like physical activity are recommended despite a lack of scientific backing.
  • - A multi-center randomized controlled trial will involve 158 participants to test whether a personalized physical activity program improves quality of life (QoL) compared to standard recommendations over six months, utilizing activity trackers and regular assessments.
  • - The trial aims to address challenges posed by the diversity of PCD cases and age variation through stratified randomization, emphasizing individualized approaches and maintaining close contact with trainers to enhance outcomes.
View Article and Find Full Text PDF

Background: Primary ciliary dyskinesia (PCD) is a congenital disorder characterized by chronic respiratory morbidity. To date, there is no information on PCD-specific preference-based quality of life measures such as health utilities (HU). We cross-sectionally assessed HU in adult PCD patients and explored relationships with genotype, phenotype and quality of life (QOL)-PCD scales.

View Article and Find Full Text PDF

Translation of the quality of life questionnaire for primary ciliary dyskinesia (QOL-PCD) into Hebrew: The Israeli experience.

Pediatr Pulmonol

May 2022

Pediatric Pulmonology Unit, Dana-Dwek Children's Hospital, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Background: Patients with primary ciliary dyskinesia (PCD) have chronic morbidities affecting their quality of life (QOL). Health-related QOL (HRQOL) has been recognized as an important tool for assessing the burden of PCD on patients and their families. A PCD-specific HRQOL questionnaire (QOL-PCD) was developed and validated for the English-speaking populations.

View Article and Find Full Text PDF
Article Synopsis
  • Primary ciliary dyskinesia (PCD) is a rare genetic disorder affecting 1 in 10,000 people, primarily impacting the respiratory system and leading to various ear, nose, and throat (ENT) issues among patients.
  • The EPIC-PCD study aims to create a comprehensive, multinational cohort to longitudinally assess the severity and spectrum of ENT disease in PCD patients, while exploring its correlations with lung disease and prognosis factors.
  • Ethical approval has been granted for the study, and findings will be disseminated through scientific publications and presentations, contributing to broader understanding of PCD and its implications for patient care.
View Article and Find Full Text PDF

Background: The QOL-PCD questionnaire is a recently developed Health Related Quality of Life (HRQoL) instrument for Primary Ciliary Dyskinesia. The aim of this study was to translate the adult QOL-PCD questionnaire into Greek language and to conduct psychometric validation to assess its performance.

Methods: Forward translations to Greek and backward translation to English were performed, followed by cognitive interviews in 12 adult PCD patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!